ArticleClinicoEconomics and outcomes research : CEOR2017

Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis.

Kirk Geale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.